Catalyst Wire Dossier Catalyst Wire Dossier

BLU-222

· Blueprint Medicines Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BLU-222, covering 2025-11-28 to 2025-11-28. Get the full timeline:

Most recent: Clinical Trial Update: (VELA) Study of BLU-222 in Advanced Solid Tumors [Phase 1]

See pricing